Ammira Al-Shabeeb First Newborn Genome Screening Program in the Middle East
Ammira Al-Shabeeb, Director and Lead Principal Investigator at Sidra Medicine, shared a post by Stephen Kingsmore, President/CEO at Rady Children’s Institute for Genomic Medicine on LinkedIn:
“Joining BeginNGS Consortium marks a milestone for Sidra Medicine and NOOR-QATAR—the first newborn genome screening program in the Middle East—advancing better care for every newborn.”
Quoting Stephen Kingsmore‘s post:
“Our ability to diagnose and treat rare diseases depends on understanding how they present across diverse populations. That’s why international expansion of BeginNGS is so important. It allows us to learn from global incidence patterns and connect newborns to lifesaving treatments before symptoms take hold. I’m thrilled to welcome Sidra Medicineas the first international member of the BeginNGS Consortium.”
More posts featuring Ammira Al-Shabeeb on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023